KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)
South Korea
· Delayed Price · Currency is KRW
16,450
+330 (2.05%)
Jan 21, 2025, 9:00 AM KST
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 179.42 billion as of January 22, 2025. Its market cap has decreased by -27.69% in one year.
Market Cap
179.42B
Enterprise Value
163.50B
Revenue
79.80B
Ranking
n/a
PE Ratio
59.73
Stock Price
16,450.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 179.42B, a decrease of -2.37%. That is a compound annual growth rate of -0.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 21, 2025 | 179.42B | 7.45% |
Dec 30, 2024 | 166.98B | -35.26% |
Dec 28, 2023 | 257.94B | 10.51% |
Dec 29, 2022 | 233.40B | -55.92% |
Dec 30, 2021 | 529.52B | 118.69% |
Dec 30, 2020 | 242.13B | 31.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 356.66T |
SK hynix | 147.80T |
LG Energy Solution | 82.02T |
Samsung Biologics Co.,Ltd. | 72.24T |
Hyundai Motor Company | 46.50T |
Kia Corporation | 39.35T |
Celltrion | 38.18T |
KB Financial Group | 33.18T |